NYSE:WAT

Waters (WAT) Stock Price, News & Analysis

Waters logo
$455.19 +1.77 (+0.39%)
As of 10:33 AM Eastern
This is a fair market value price provided by Massive. Learn more.

About Waters Stock (NYSE:WAT)

Advanced

Key Stats

Today's Range
$450.16
▼
$458.33
50-Day Range
$402.33
▼
$479.97
52-Week Range
$282.77
▼
$483.33
Volume
37,286 shs
Average Volume
959,094 shs
Market Capitalization
$44.74 billion
P/E Ratio
195.53
Dividend Yield
N/A
Price Target
$475.48
Consensus Rating
Moderate Buy

Company Overview

Waters Corporation develops and supplies analytical instruments, software, and consumables used to identify, measure, and characterize chemical and biological materials. Its products include liquid chromatography and mass spectrometry systems, which help customers analyze complex samples.

The company serves pharmaceutical and biotechnology businesses, academic and government laboratories, and customers in fields such as food, environmental testing, and materials science. Waters operates internationally, with customers and operations across multiple regions.

Founded in 1958 by James L. Waters, the company is headquartered in Milford, Massachusetts. Its technologies support drug research and development, manufacturing quality control, and other laboratory testing and analysis.

AI Generated. May Contain Errors.

Waters Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
46th Percentile Overall Score

WAT MarketRank™: 
2.30887053809 of 5 stars

Waters scored higher than 46% of companies evaluated by MarketBeat, and ranked 596th out of 877 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Waters has received a consensus rating of Moderate Buy. The company's average rating score is 2.79, and is based on 1 strong buy rating, 17 buy ratings, 6 hold ratings, and no sell ratings.

  • Upside/Downside

    The consensus price target for Waters is close to its current price, suggesting limited near-term upside or downside.

  • Amount of Analyst Coverage

    Waters has been the subject of 14 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Waters' stock forecast and price target.
  • Earnings Growth

    Earnings for Waters are expected to grow by 13.17% in the coming year, from $14.65 to $16.58 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Waters is 194.31, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.40.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Waters is 194.31, which means that it is trading at a more expensive P/E ratio than the Healthcare sector average P/E ratio of about 33.73.

  • Price to Earnings Growth Ratio

    Waters has a PEG Ratio of 2.63. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Waters has a P/B Ratio of 2.91. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    3.40% of the float of Waters has been sold short.
  • Short Interest Ratio / Days to Cover

    Waters has a short interest ratio ("days to cover") of 3.63, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Waters has recently increased by 4.33%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Waters does not currently pay a dividend.

  • Dividend Growth

    Waters does not have a long track record of dividend growth.

  • News Sentiment

    Waters has a news sentiment score of 0.31. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.59 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 18 news articles for Waters this week, compared to 9 articles on an average week.
  • Search Interest

    Only 6 people have searched for WAT on MarketBeat in the last 30 days. This is a decrease of -40% compared to the previous 30 days.
  • MarketBeat Follows

    6 people have added Waters to their MarketBeat watchlist in the last 30 days. This is an increase of 500% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Waters insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    0.31% of the stock of Waters is held by insiders.

  • Percentage Held by Institutions

    94.01% of the stock of Waters is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Waters' insider trading history.
Receive WAT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Waters and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

WAT Stock News Headlines

Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratings' latest research says 2026 could be very rough for some well-known stocks. A major shift now taking shape in the market could hit some of America's most-loved names hard. Weiss analysts have pinpointed five stocks they believe investors should steer clear of while it plays out.tc pixel
What Was Waters Telling You Before Its Stock Ran?
Crystal Waters Brings Music, Community and Giving Back
Tungsten Mining Releases Watershed Project Development Video
Watershed DFS Reports A$1.57 Billion Pre-Tax NPV
See More Headlines

WAT Stock Analysis - Frequently Asked Questions

Waters' stock was trading at $380.45 at the beginning of 2026. Since then, WAT shares have increased by 19.0% and is now trading at $452.7420.

Waters Corporation (NYSE:WAT) announced its earnings results on Tuesday, November, 3rd. The medical instruments supplier reported $4.10 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $4.00 by $0.10. Waters's revenue for the quarter was up 120.9% on a year-over-year basis.
Read the conference call transcript
.

The following companies are subsidiaries of Waters: Andrew Alliance S.A, Andrew Alliance, Rubotherm, MPE Orbur Group Ltd. (UK), ElectroForce, Blue Reference Inc., Baehr Thermoanalyse GmbH, and others.

Top institutional shareholders of Waters include State Street Corp (4.50%), Aberdeen Group plc (2.97%), Mawer Investment Management Ltd. (1.00%) and First Eagle Investment Management LLC (0.96%). Insiders that own company stock include Christopher A Kuebler, Wei Jiang, Linda Baddour and Richard H Fearon.
View institutional ownership trends
.

Shares of WAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Waters investors own include NVIDIA (NVDA), Lam Research (LRCX), Thermo Fisher Scientific (TMO), Intuitive Surgical (ISRG), Agilent Technologies (A), Vertex Pharmaceuticals (VRTX) and Walmart (WMT).

Company Calendar

Last Earnings
11/03/2026
Today
11/17/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Life Sciences Tools & Services
Sub-Industry
Life Sciences Tools & Services
Current Symbol
NYSE:WAT
CIK
1000697
Employees
7,900
Year Founded
1958

Price Target and Rating

High Price Target
$536.00
Low Price Target
$400.00
Potential Upside/Downside
+4.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.79
Research Coverage
24 Analysts

Profitability

EPS (Trailing Twelve Months)
$2.33
Trailing P/E Ratio
195.26
Forward P/E Ratio
27.35
P/E Growth
2.63
Net Income
$642.63 million
Net Margins
1.75%
Pretax Margin
1.94%
Return on Equity
9.91%
Return on Assets
6.11%

Debt

Debt-to-Equity Ratio
0.29
Current Ratio
1.89
Quick Ratio
0.40

Sales & Book Value

Annual Sales
$3.17 billion
Price / Sales
14.08
Cash Flow
$16.31 per share
Price / Cash Flow
27.80
Book Value
$155.58 per share
Price / Book
2.91

Miscellaneous

Outstanding Shares
98,290,000
Free Float
97,981,000
Market Cap
$44.57 billion
Optionable
Optionable
Beta
1.16

Social Links

7 Energy Stocks to Buy and Hold Forever Cover

Oil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.

Get This Free Report

This page (NYSE:WAT) was last updated on 11/17/2026 by MarketBeat.com Staff.
From Our Partners